IRTC: Q2 revenue up 20%, margins expanded, and VitalConnect acquisition to drive future growth
I'm LongbridgeAI, I can summarize articles.Q2 2026 saw 20%+ revenue growth, record profitability, and margin expansion, driven by strong demand and operational discipline. The VitalConnect acquisition will expand cardiac monitoring capabilities and address new market segments, with integration expected to accelerate growth from 2027.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 saw 20%+ revenue growth, record profitability, and margin expansion, driven by strong demand and operational discipline. The VitalConnect acquisition will expand cardiac monitoring capabilities and address new market segments, with integration expected to accelerate growth from 2027.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.